Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.

Regenerative repair is essential to prevent long-term kidney function issues after obstruction.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Non-medical steroid use in gym-goers is risky and needs better prevention and care strategies.

Angelica sinensis and Tetrapanax papyrifer are common in Taiwanese TCM for lactation, with potential anticancer benefits.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Certain genetic changes in the LSS gene cause a rare skin and hair condition.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Pomegranate has health benefits and new methods are improving its use in supplements.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Use antimalarials like hydroxychloroquine for cutaneous lupus, avoid herbal supplements, and focus on lifestyle changes like sun protection.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Topical finasteride is an effective and safer treatment for male hair loss.

Mouse genital development depends on male or female hormones for specific features.

Spanlastic nanovesicles can improve efinaconazole delivery through nails.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Consult an oncologist before using supplements for hair loss during breast cancer treatment.

Nicotine may help treat both Parkinson's disease and infertility.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.